AMETEK, Inc. filings document regulatory disclosures for a NYSE-listed industrial technology company with common stock registered under Section 12(b). Recent Form 8-K reports cover operating results, dividend actions, acquisition-related material events, board appointments, officer transitions and shareholder voting matters.
Proxy materials and annual meeting disclosures address director elections, executive compensation, auditor ratification and other governance matters. AMETEK's filings also describe capital-structure information, material-event exhibits and business reporting for its Electronic Instruments and Electromechanical operations.
AMETEK’s chief commercial officer, Giovanna M. Speranza, reported equity awards and related share movements. On March 18, 2025 she received 890 restricted stock units and 2,720 stock options, each tied to AMETEK common stock at an exercise price of $176.08.
On March 19, 2025, 230 restricted stock units were converted into common stock at $0, and 104 of those shares were withheld at $177.07 per share to cover taxes. After these transactions she directly owned 31,560 AMETEK common shares, plus 890 restricted stock units, 2,720 stock options, and 460 additional restricted stock units subject to vesting schedules beginning March 18, 2026 and March 22, 2024.
AMETEK, Inc. announced that its Board of Directors has approved a 10% increase in the quarterly cash dividend on its common stock, raising it to $0.34 per share from $0.31. The first quarter dividend will be payable on March 31, 2026 to shareholders of record as of March 16, 2026.
This increase lifts the company’s indicated annual dividend rate to $1.36 per share, reflecting management’s confidence in AMETEK’s financial strength and ongoing cash generation. The company highlights strong growth, solid cash flow, and a continued focus on strategic acquisitions alongside returning cash to shareholders.
AMETEK, Inc. furnished an update on its performance and strategy by sharing two press releases. The company announced its financial results for the twelve months ended December 31, 2025, highlighting what it describes as record fourth quarter and full year results. These details are contained in a press release attached as an exhibit.
AMETEK also reported that it has acquired LKC Technologies, and provided a separate press release with additional information about this transaction. Both releases are furnished, not filed, meaning they are not automatically incorporated into other securities law filings unless specifically referenced.
AMETEK, Inc. insider holdings are reported for a Senior Vice President and Controller as of 01/06/2026. The reporting person holds 43,747 shares of AMETEK common stock directly, plus 711 common stock units in a SERP account and 3,149 common stock units through a 401(k) plan.
The filing also lists stock options on AMETEK common stock. These include options on 583 shares at an exercise price of $138.46 expiring on 03/22/2033, options on 939 shares at $181.93 expiring on 03/19/2034, and options on 1,381 shares at $176.08 expiring on 03/18/2035. Each grant vests in three equal annual installments beginning on its stated start date.
AMETEK Inc. director reports stock gift
A director of AMETEK Inc. reported a disposition of 1,250 shares of AMETEK common stock on 12/30/2025 coded as "G," indicating a gift transaction. The shares were transferred at a reported price of $0, consistent with a non-cash gift rather than a market sale. Following this transaction, the director beneficially owns 4,690 shares of AMETEK common stock in direct ownership.
AMETEK Inc. (AME) senior vice president and comptroller reported a small gift of company stock. On 12/26/2025, the officer transferred 19 shares of Common Stock in a transaction coded “G” (gift) at a reported price of $0 per share.
After this transaction, the officer beneficially owns 22,097 shares held directly in a 401(k) plan, 3,441 shares held indirectly through a 401(k) plan common stock/SERP arrangement, and 3,283 shares held directly outside those plans. The filing reports no derivative securities.
AMETEK Inc. officer reports option exercise and share sale. A senior vice president and comptroller exercised stock options for 6,388 shares of AMETEK common stock on 12/22/2025 at an exercise price of $85.45 per share and immediately sold 6,388 shares on the same date. The reported sale price is $205.0548 per share, with actual sale prices ranging from $204.57 to $205.49. After these transactions, the reporting person holds 22,116 AMETEK shares directly and 3,441 shares indirectly through a 401(k) plan. The underlying stock options, which were scheduled to become exercisable in three equal annual installments beginning on May 9, 2020, now show a remaining balance of zero and had an expiration date of May 9, 2029.
AMETEK, Inc. has filed a notice for the planned sale of 6,388 shares of its common stock through broker Charles Schwab & Co., Inc. on the NYSE. The shares to be sold have an stated aggregate market value of $1,309,890.00. They were acquired on 12/22/2025 via an employee stock option exercise using a broker payment for a cashless exercise on the same date. Shares of AMETEK common stock outstanding were 230,203,873 as of the figures provided; this is a baseline figure, not the amount being sold.
AMETEK, Inc. reported an insider transaction by its Electronic Instruments president involving company common stock on 12/15/2025. The officer exercised stock options for 14,310 shares of common stock at an exercise price of $63.37 per share; these options became exercisable in three equal annual installments beginning on March 20, 2021.
On the same date, the officer sold 14,310 shares of AMETEK common stock at a price of $202.1131 per share, with sale prices ranging from $202.00 to $202.44. After these transactions, the officer directly owned 42,589 shares, held 3,029 shares through a 401k plan, 348 shares held by a spouse, and 13,553 shares of Common Stock/SERP, with no stock options remaining.
AMETEK, Inc. has filed a notice that an employee plans to sell 14,310 shares of its common stock on or about 12/15/2025 on the NYSE through Charles Schwab. The filing reports an aggregate market value for the planned sale of $2,892,238 based on the market data used in the form.
The shares were acquired the same day through an employee stock option exercise structured as a broker-facilitated cashless exercise. The form indicates that 230,203,873 shares of AMETEK common stock are outstanding, so the planned sale represents a small portion of the company’s equity base. The seller also represents that they are not aware of any material adverse information about AMETEK’s current or prospective operations that has not been publicly disclosed.